99 Recruiting Ulcerative Colitis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Ulcerative Colitis
Related Conditions
Top Recruiting Ulcerative Colitis Studies
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
📍 Digestive Health Specialists ( Site 0135) — Dothan, Alabama
View Study & Checklist ➔Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
📍 UCSD — San Diego, California
View Study & Checklist ➔A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants
📍 OptumInsight Life Sciences Inc — Eden Prairie, Minnesota
View Study & Checklist ➔CP101 for the Treatment of Ulcerative Colitis
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
📍 GastroIntestinal BioSciences — Los Angeles, California
View Study & Checklist ➔Angiographic Delivery of AD-MSC for Ulcerative Colitis
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
📍 Digestive Health Specialists Of The Southeast — Dothan, Alabama
View Study & Checklist ➔Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
📍 Medizinische Universitaet Innsbruck — Innsbruck,
View Study & Checklist ➔Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
📍 San Diego Gastroenterology — San Diego, California
View Study & Checklist ➔A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
📍 Digestive Health Specialists — Dothan, Alabama
View Study & Checklist ➔ABTECT - Maintenance
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
View Study & Checklist ➔Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
📍 Del Sol Research Management, LLC — Tucson, Arizona
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
📍 Gastro SB /ID# 258331 — Chula Vista, California
View Study & Checklist ➔An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
📍 Clinical Research Facility — Murrieta, California
View Study & Checklist ➔A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
📍 Gastro Health Research - St. Vincent'S East /ID# 275089 — Birmingham, Alabama
View Study & Checklist ➔Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis
📍 Rush University Medical Center — Chicago, Illinois
View Study & Checklist ➔Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Onyx Clinical Research (Clinic Location) — Peoria, Arizona
View Study & Checklist ➔A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
📍 AnaptysBio Investigational Site 10-115 — Phoenix, Arizona
View Study & Checklist ➔A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Om Research LLC — Lancaster, California
View Study & Checklist ➔Aquamin® as an Adjuvant Intervention for Ulcerative Colitis
📍 The University of Michigan — Ann Arbor, Michigan
View Study & Checklist ➔Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
📍 Phoenix Children's Hospital /ID# 250135 — Phoenix, Arizona
View Study & Checklist ➔An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
📍 Center for Digestive Health (Colonoscopy Location) — Dothan, Alabama
View Study & Checklist ➔An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
📍 Gedyt /ID# 249611 — Ciudad Autonoma de Buenos Aire, Buenos Aires F.D.
View Study & Checklist ➔Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Naturopathic Approaches to Ulcerative Colitis
📍 Helfgott Research Institute - National University of Natural Medicine — Portland, Oregon
View Study & Checklist ➔Combination CurQD and Vedolizumab in Ulcerative Colitis
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
📍 Miami Clinical Research — Miami, Florida
View Study & Checklist ➔A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
📍 Takeda Site — Cambridge, Massachusetts
View Study & Checklist ➔A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
📍 Site 024 — Canoga Park, California
View Study & Checklist ➔Study of Novel Therapeutics for Acute Remedy of Colitis
📍 Brigham and Women's Hospital — Chestnut Hill, Massachusetts
View Study & Checklist ➔A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
📍 Investigational Site Number: 8400009 — Escondido, California
View Study & Checklist ➔An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Onyx Clinical Research - Site Number: 8400021 — Peoria, Arizona
View Study & Checklist ➔A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
📍 AZ Gastro Care - Chandler — Chandler, Arizona
View Study & Checklist ➔A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
📍 Digestive Health Specialsits — Dothan, Alabama
View Study & Checklist ➔Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
📍 GI Alliance — Sun City, Arizona
View Study & Checklist ➔A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
📍 Gastro Health — Birmingham, Alabama
View Study & Checklist ➔The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Personalized Anti-Inflammatory Fibres in Ulcerative Colitis
📍 University of Alberta Hospital — Edmonton, Alberta
View Study & Checklist ➔A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
📍 Phoenix Children's Hospital — Phoenix, Arizona
View Study & Checklist ➔Mirikizumab Real World Protocol
📍 South Denver Gastroenterology — Denver, Colorado
View Study & Checklist ➔